Literature DB >> 11304042

Unusual triplet expansion associated with neurogenic changes in a family with oculopharyngeal muscular dystrophy.

R Schober1, W Kress, F Grahmann, S Kellermann, P Baum, S Günzel, A Wagner.   

Abstract

The occasional observation of neurogenic features in oculopharyngeal muscular dystrophy (OPMD) is unclear both in nosological and in etiological respects. Studies are reported here of a family with autosomal-dominant OPMD involving seven members over three generations. In three of them muscle biopsies were performed. Two of the patients (a 45-year-old sister and a 57-year-old brother of the third generation) were studied in more detail and, in addition to the typical changes of OPMD, showed a neurogenic component both by electrophysiology and morphology. Molecular genetic investigations revealed a repeat unit of (GCG/GCA)13 in the first exon of the poly(A)binding-protein2 gene in both siblings. A possible association of this unusually long triplet repeat extension with the atypical phenotype is considered and has to be verified in other cases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11304042     DOI: 10.1046/j.1440-1789.2001.00374.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  5 in total

1.  Genotype and phenotype study of 34 Spanish patients diagnosed with oculopharyngeal muscular dystrophy.

Authors:  Mireia Tondo; Josep Gámez; Eduardo Gutiérrez-Rivas; Ramón Medel-Jiménez; Loreto Martorell
Journal:  J Neurol       Date:  2012-01-10       Impact factor: 4.849

2.  Genetic heterogeneity in 30 German patients with oculopharyngeal muscular dystrophy.

Authors:  T Müller; M Deschauer; F Kolbe-Fehr; St Zierz
Journal:  J Neurol       Date:  2006-04-20       Impact factor: 4.849

3.  Oculopharyngeal muscular dystrophy (OPMD): analysis of the PABPN1 gene expansion sequence in 86 patients reveals 13 different expansion types and further evidence for unequal recombination as the mutational mechanism.

Authors:  David O Robinson; Simon R Hammans; Steven P Read; Julie Sillibourne
Journal:  Hum Genet       Date:  2005-01-12       Impact factor: 4.132

Review 4.  PABPN1: molecular function and muscle disease.

Authors:  Ayan Banerjee; Luciano H Apponi; Grace K Pavlath; Anita H Corbett
Journal:  FEBS J       Date:  2013-05-24       Impact factor: 5.542

5.  Lithium chloride attenuates cell death in oculopharyngeal muscular dystrophy by perturbing Wnt/β-catenin pathway.

Authors:  A Abu-Baker; J Laganiere; R Gaudet; D Rochefort; B Brais; C Neri; P A Dion; G A Rouleau
Journal:  Cell Death Dis       Date:  2013-10-03       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.